Evidence map›Paper›PMID 31174492›Full record

ArticleBMC cancer2019

Geospatial analyses identify regional hot spots of diffuse gastric cancer in rural Central America.

Ricardo L Dominguez, Charlotte B Cherry, Dago Estevez-Ordonez, Robertino Mera, Veronica Escamilla, Michael Pawlita, Tim Waterboer, Keith T Wilson, Richard M Peek, Gloria Tavera and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. High Seroprevalence ofGastroenterology research · 2025
    Article
  3. Review
  4. Population-Based Study of Gastric Cancer Survival and Associations in Rural Western Honduras.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Ricardo L DominguezHospital de Occidente, Santa Rosa de Copan, Copan, Honduras.
Charlotte B CherryOffice of Public Health Informatics & Analytics, Tennessee Department of Public Health, Nashville, TN, USA.
Dago Estevez-OrdonezVanderbilt Ingram Cancer Center (VICC), Vanderbilt University Medical Center, Nashville, USA.
Robertino MeraDivision of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, USA.
Veronica EscamillaCarolina Population Center, University of North Carolina, Chapel Hill, USA.
Michael PawlitaDivision of Molecular Diagnostics of Oncogenic Infections, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Tim WaterboerDivision of Molecular Diagnostics of Oncogenic Infections, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Keith T WilsonDivision of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, USA.
Richard M PeekDivision of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, USA.
Gloria TaveraDepartment of Population and Quantitative Health Sciences and Institute of Computational Biology, Case Western Reserve University, Cleveland, USA.
Scott M WilliamsDepartment of Population and Quantitative Health Sciences and Institute of Computational Biology, Case Western Reserve University, Cleveland, USA.
Margaret L GulleyDepartment of Pathology, University of North Carolina, Chapel Hill, USA.
Michael EmchDepartment of Geography, University of North Carolina, Chapel Hill, USA.
Douglas R MorganVanderbilt Ingram Cancer Center (VICC), Vanderbilt University Medical Center, Nashville, USA. drmorgan@uabmc.edu.
Vanderbilt University Medical Center · USUniversity of North Carolina at Chapel Hill · USCase Western Reserve University · USGerman Cancer Research Center · DEHeidelberg University · DETennessee Department of Health · USUniversity of Alabama at Birmingham · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STACIE B DUSETZINA · 1995 to 2026
$172.8M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Role of Iron and B-Catenin Activation in Gastric CarcinogenesisP01CA116087 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kevin L Schey · 2009 to 2026
$27.5M
Project 3 - Molecular Signatures of Gastric Carcinogenesis in the Host Response to H. pyloriP01CA028842 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILSON, KEITH T. · 1985 to 2019
$15.8M
H.Pylori Relationship to Digestive Diseases and CancerR01CA077955 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2003 to 2026
$9.7M
Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)R25TW009337 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HEIMBURGER, DOUGLAS CORBETT, VERMUND, STEN H. · 2012 to 2016
$6.3M
Targeted chemoprevention of gastric carcinogenesis in high risk populationsR01CA190612 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MORGAN, DOUGLAS, WILSON, KEITH T. · 2014 to 2018
$3.0M
NRSA Training CoreTL1TR002549 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI HARDING, CLIFFORD V · 2018 to 2022
$2.9M
Clinical and Translational Science Collaborative of ClevelandTL1TR000441 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$2.8M
Gastric Cancer Epidemiology Initiative in Central AmericaK07CA125588 · NCI · VANDERBILT UNIVERSITY · PI MORGAN, DOUGLAS · 2007 to 2011
$680k
BLRD VA I01 BX001453CCR NIH HHS HHSN261200800001CFIC NIH HHS R25 TW009337NCATS NIH HHS TL1 TR000441NCATS NIH HHS TL1 TR002549NCI NIH HHS HHSN261200800001ENCI NIH HHS K07 CA125588NCI NIH HHS P01 CA028842NCI NIH HHS P01 CA028842, K07 CA125588, PAR-15-155, HHSN261200800001E, P30 CA068485, R01 CA190612NCI NIH HHS P01 CA116087NCI NIH HHS P30 CA068485NCI NIH HHS R01 CA077955NCI NIH HHS R01 CA190612NICHD NIH HHS P2C HD050924NIDDK NIH HHS P30 DK058404NIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

backgroundGeospatial technology has facilitated the discovery of disease distributions and etiology and helped target prevention programs. Globally, gastric cancer is the leading infection-associated cancer, and third leading cause of cancer mortality worldwide, with marked geographic variation. Central and South America have a significant burden, particularly in the mountainous regions. In the context of an ongoing population-based case-control study in Central America, our aim was to examine the spatial epidemiology of gastric cancer subtypes and H. pylori virulence factors.

methodsPatients diagnosed with gastric cancer from 2002 to 2013 in western Honduras were identified in the prospective gastric cancer registry at the principal district hospital. Diagnosis was based on endoscopy and confirmatory histopathology. Geospatial methods were applied using the ArcGIS v10.3.1 and SaTScan v9.4.2 platforms to examine regional distributions of the gastric cancer histologic subtypes (Lauren classification), and the H. pylori CagA virulence factor. Getis-Ord-Gi hot spot and Discrete Poisson SaTScan statistics, respectively, were used to explore spatial clustering at the village level (30-50 rural households), with standardization by each village's population. H. pylori and CagA serologic status was determined using the novel H. pylori multiplex assay (DKFZ, Germany).

resultsThree hundred seventy-eight incident cases met the inclusion criteria (mean age 63.7, male 66.3%). Areas of higher gastric cancer incidence were identified. Significant spatial clustering of diffuse histology adenocarcinoma was revealed both by the Getis-Ord-GI* hot spot analysis (P-value < 0.0015; range 0.00003-0.0014; 99%CI), and by the SaTScan statistic (P-value < 0.006; range 0.0026-0.0054). The intestinal subtype was randomly distributed. H. pylori CagA had significant spatial clustering only in association with the diffuse histology cancer hot spot (Getis-Ord-Gi* P value ≤0.001; range 0.0001-0.0010; SaTScan statistic P value 0.0085). In the diffuse gastric cancer hot spot, the lowest age quartile range was 21-46 years, significantly lower than the intestinal cancers (P = 0.024).

conclusionsGeospatial methods have identified a significant cluster of incident diffuse type adenocarcinoma cases in rural Central America, suggest of a germline genetic association. Further genomic and geospatial analyses to identify potential spatial patterns of genetic, bacterial, and environmental risk factors may be informative.

Indexed as

Rural HealthAgedCase-Control StudiesCentral AmericaDisease SusceptibilityFemaleGeographyHelicobacter InfectionsHelicobacter pyloriHumansMaleMiddle AgedRisk AssessmentRisk FactorsSpatial AnalysisStomach NeoplasmsCA-4Central AmericaDiffuse gastric cancerGastric cancerGermline mutationsHondurasH. pylori

Identifiers

PMID31174492
PMCPMC6554991
OpenAlexW2954300628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.